These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 24201308)
1. The 2-methoxy methyl analogue of salvinorin A attenuates cocaine-induced drug seeking and sucrose reinforcements in rats. Morani AS; Ewald A; Prevatt-Smith KM; Prisinzano TE; Kivell BM Eur J Pharmacol; 2013 Nov; 720(1-3):69-76. PubMed ID: 24201308 [TBL] [Abstract][Full Text] [Related]
2. The C-2 derivatives of salvinorin A, ethoxymethyl ether Sal B and β-tetrahydropyran Sal B, have anti-cocaine properties with minimal side effects. Ewald AWM; Bosch PJ; Culverhouse A; Crowley RS; Neuenswander B; Prisinzano TE; Kivell BM Psychopharmacology (Berl); 2017 Aug; 234(16):2499-2514. PubMed ID: 28536865 [TBL] [Abstract][Full Text] [Related]
3. Pharmacology and anti-addiction effects of the novel κ opioid receptor agonist Mesyl Sal B, a potent and long-acting analogue of salvinorin A. Simonson B; Morani AS; Ewald AW; Walker L; Kumar N; Simpson D; Miller JH; Prisinzano TE; Kivell BM Br J Pharmacol; 2015 Jan; 172(2):515-31. PubMed ID: 24641310 [TBL] [Abstract][Full Text] [Related]
4. Kappa Opioid Receptor Agonist Mesyl Sal B Attenuates Behavioral Sensitization to Cocaine with Fewer Aversive Side-Effects than Salvinorin A in Rodents. Kivell BM; Paton KF; Kumar N; Morani AS; Culverhouse A; Shepherd A; Welsh SA; Biggerstaff A; Crowley RS; Prisinzano TE Molecules; 2018 Oct; 23(10):. PubMed ID: 30314288 [TBL] [Abstract][Full Text] [Related]
5. A single injection of a novel κ opioid receptor agonist salvinorin A attenuates the expression of cocaine-induced behavioral sensitization in rats. Morani AS; Schenk S; Prisinzano TE; Kivell BM Behav Pharmacol; 2012 Apr; 23(2):162-70. PubMed ID: 22293826 [TBL] [Abstract][Full Text] [Related]
6. Effect of kappa-opioid receptor agonists U69593, U50488H, spiradoline and salvinorin A on cocaine-induced drug-seeking in rats. Morani AS; Kivell B; Prisinzano TE; Schenk S Pharmacol Biochem Behav; 2009 Dec; 94(2):244-9. PubMed ID: 19747933 [TBL] [Abstract][Full Text] [Related]
7. MP1104, a mixed kappa-delta opioid receptor agonist has anti-cocaine properties with reduced side-effects in rats. Atigari DV; Uprety R; Pasternak GW; Majumdar S; Kivell BM Neuropharmacology; 2019 May; 150():217-228. PubMed ID: 30768946 [TBL] [Abstract][Full Text] [Related]
8. Salvinorin A analogs and other κ-opioid receptor compounds as treatments for cocaine abuse. Kivell BM; Ewald AW; Prisinzano TE Adv Pharmacol; 2014; 69():481-511. PubMed ID: 24484985 [TBL] [Abstract][Full Text] [Related]
9. Salvinorin B derivatives, EOM-Sal B and MOM-Sal B, produce stimulus generalization in male Sprague-Dawley rats trained to discriminate salvinorin A. Peet MM; Baker LE Behav Pharmacol; 2011 Sep; 22(5-6):450-7. PubMed ID: 21814135 [TBL] [Abstract][Full Text] [Related]
10. 2-Methoxymethyl-salvinorin B is a potent kappa opioid receptor agonist with longer lasting action in vivo than salvinorin A. Wang Y; Chen Y; Xu W; Lee DY; Ma Z; Rawls SM; Cowan A; Liu-Chen LY J Pharmacol Exp Ther; 2008 Mar; 324(3):1073-83. PubMed ID: 18089845 [TBL] [Abstract][Full Text] [Related]
11. The Kappa Opioid Receptor Agonist 16-Bromo Salvinorin A Has Anti-Cocaine Effects without Significant Effects on Locomotion, Food Reward, Learning and Memory, or Anxiety and Depressive-like Behaviors. van de Wetering R; Ewald A; Welsh S; Kornberger L; Williamson SE; McElroy BD; Butelman ER; Prisinzano TE; Kivell BM Molecules; 2023 Jun; 28(12):. PubMed ID: 37375403 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and κ-opioid receptor activity of furan-substituted salvinorin A analogues. Riley AP; Groer CE; Young D; Ewald AW; Kivell BM; Prisinzano TE J Med Chem; 2014 Dec; 57(24):10464-75. PubMed ID: 25426797 [TBL] [Abstract][Full Text] [Related]
14. Comparison of the diuretic effects of chemically diverse kappa opioid agonists in rats: nalfurafine, U50,488H, and salvinorin A. Inan S; Lee DY; Liu-Chen LY; Cowan A Naunyn Schmiedebergs Arch Pharmacol; 2009 Mar; 379(3):263-70. PubMed ID: 18925386 [TBL] [Abstract][Full Text] [Related]
15. Fenobam sulfate inhibits cocaine-taking and cocaine-seeking behavior in rats: implications for addiction treatment in humans. Keck TM; Yang HJ; Bi GH; Huang Y; Zhang HY; Srivastava R; Gardner EL; Newman AH; Xi ZX Psychopharmacology (Berl); 2013 Sep; 229(2):253-65. PubMed ID: 23615919 [TBL] [Abstract][Full Text] [Related]
16. "Effects of the novel relatively short-acting kappa opioid receptor antagonist LY2444296 in behaviors observed after chronic extended-access cocaine self-administration in rats". Valenza M; Butelman ER; Kreek MJ Psychopharmacology (Berl); 2017 Aug; 234(15):2219-2231. PubMed ID: 28550455 [TBL] [Abstract][Full Text] [Related]
17. Differential effects of the novel kappa opioid receptor antagonist, JDTic, on reinstatement of cocaine-seeking induced by footshock stressors vs cocaine primes and its antidepressant-like effects in rats. Beardsley PM; Howard JL; Shelton KL; Carroll FI Psychopharmacology (Berl); 2005 Nov; 183(1):118-26. PubMed ID: 16184376 [TBL] [Abstract][Full Text] [Related]
18. Blockade of dopamine D3 receptors in the nucleus accumbens and central amygdala inhibits incubation of cocaine craving in rats. Xi ZX; Li X; Li J; Peng XQ; Song R; Gaál J; Gardner EL Addict Biol; 2013 Jul; 18(4):665-77. PubMed ID: 22913325 [TBL] [Abstract][Full Text] [Related]
19. A novel mGluR5 antagonist, MFZ 10-7, inhibits cocaine-taking and cocaine-seeking behavior in rats. Keck TM; Zou MF; Bi GH; Zhang HY; Wang XF; Yang HJ; Srivastava R; Gardner EL; Xi ZX; Newman AH Addict Biol; 2014 Mar; 19(2):195-209. PubMed ID: 24001208 [TBL] [Abstract][Full Text] [Related]